California sues pro-life organizations over claims of… | WORLD
Logo
Sound journalism, grounded in facts and Biblical truth | Donate

California sues pro-life organizations over claims of abortion pill reversal


California Attorney General Rob Bonta on Thursday sued to stop Heartbeat International and RealOptions Obria from promoting a treatment to stop chemical abortions. The organizations say women can reverse a drug-induced abortion by taking a high dose of the hormone progesterone within 72 hours of taking mifepristone—the first of two drugs typically used in a regimen for such an abortion. Bonta said the claims are unproven and violate the state’s false advertising law. Heartbeat International operates pregnancy resource centers around the country. RealOptions runs five pro-life clinics in Northern California.

What have other states said about the treatment? More than 10 states have laws that require abortionists to provide patients with information about reversal options before performing the procedure. Planned Parenthood in June sued Kansas over the state’s requirement, which is part of the Women’s Right to Know Act. In Colorado, the state medical board is considering whether the reversal treatment is considered unprofessional. The medical board’s decision will determine if a law to ban the treatment in Colorado will take effect.

Dig deeper: Read Addie Offereins’ report in WORLD Magazine about how pro-life groups are fighting the expansion of abortion pill access.


Lauren Canterberry

Lauren Canterberry is a reporter for WORLD. She graduated from the World Journalism Institute and the University of Georgia with a degree in journalism, both in 2017. She worked as a local reporter in Texas and now lives in Georgia with her husband.


An actual newsletter worth subscribing to instead of just a collection of links. —Adam

Sign up to receive The Sift email newsletter each weekday morning for the latest headlines from WORLD’s breaking news team.
COMMENT BELOW

Please wait while we load the latest comments...

Comments